At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-Dose, Open-Label, Three-Period Crossover Study to Assess the Bioequivalence of Famotidine/Antacid Combination Tablets (FACT) Compared to Famotidine/Antacid EZ Chew Tablet Without Water and Famotidine/Antacid EZ Chew Tablet With Water
In Brief
A Phase 1 clinical trial evaluating famotidine (+) calcium carbonate (+) magnesium hydroxide tablet, Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water, and 1 other intervention for Heartburn. Completed, enrolled 24 participants.
Detailed Summary
A study in 24 healthy subjects to assess the bioequivalence of Famotidine/Antacid EZ Chew tablet taken without water and with water compared to the Famotidine/Antacid tablet taken with water. Subjects will be given a single dose of each treatment separated by 5 to 7 days.
Study Details
Timeline
Interventions
A single dose of famotidine/antacid tablet with 120 mL of water in one of three treatment periods
A single dose of famotidine/antacid combination EZ Chew tablet without water in one of three treatment periods
A single dose of famotidine/antacid combination EZ Chew tablet with 120 mL of water in one of three treatment periods